Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 19, 2024 16:26 ET | Source: Sermonix Pharmaceuticals Inc.

Sermonix to Host KOL Fireside Chat on Advancements in the Metastatic Breast Cancer Treatment Landscape on April 22, 2024

COLUMBUS, Ohio, April 19, 2024 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic...
March 26, 2024 08:00 ET | Source: Healis Therapeutics

Healis Therapeutics announces collaboration with Massachusetts General Hospital (MGH) and affiliates of Harvard Medical School to advance clinical-stage neuroscience research

The collaboration will focus on Healis’ clinical program studying the safety and efficacy of CKDB-501A, a BoNT/A neuromodulator, for neuropsychiatry.
December 16, 2020 09:15 ET | Source: Protagenic Therapeutics, Inc.

Dr. Maurizio Fava of Massachusetts General Hospital to Serve as Principal Investigator for PT00114 Clinical Trial

Clinical Trials of First-in-Class Peptide to Commence in 1H 2021 NEW YORK, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (OTCQB: PTIX) announced today that Dr. Maurizio Fava,...
September 27, 2018 09:00 ET | Source: FluoroPharma Medical, Inc.

FPMI Restructures CardioPET License With Massachusetts General Hospital

MONTCLAIR, NJ, Sept. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- FluoroPharma Medical Inc. (OTCQB: FPMI) announced today that it has reached an agreement with The General Hospital Corporation,...
October 31, 2017 15:29 ET | Source: National Brain Tumor Society

National Brain Tumor Society 2017 Scientific Summit Showcases Research & Treatment Development Opportunities in Neuro-Oncology Field

BOSTON, MA--(Marketwired - October 31, 2017) - National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, recently hosted its annual...
August 03, 2016 08:00 ET | Source: Editas Medicine

Editas Medicine Announces Exclusive License to Advanced CRISPR Genome Editing Technology from Massachusetts General Hospital

-- License to Engineered Forms of Cas9 Nuclease Includes High-Fidelity Cas9 and Cas9 PAM Variants -- CAMBRIDGE, Mass., Aug. 03, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a...
February 18, 2016 08:00 ET | Source: Vocera Communications

Vocera to Showcase Enterprise Solutions for Communication and Collaboration at HIMSS16

SAN JOSE, Calif., Feb. 18, 2016 (GLOBE NEWSWIRE) -- Vocera Communications, Inc. (NYSE:VCRA), the leading healthcare communications company, will showcase the Vocera Communication Platform at the...
December 09, 2015 08:00 ET | Source: Vocera Communications

Massachusetts General Hospital Improves Communication in Its Operating Rooms With Vocera

SAN JOSE, Calif., Dec. 09, 2015 (GLOBE NEWSWIRE) -- Vocera Communications (NYSE:VCRA), the leading mobile healthcare communications company, announced today that Massachusetts General Hospital (MGH)...